Menu

CME Corner

This activity has expired. CME/CE credit is no longer available and the following content may not be available or may not be up-to-date. For a list of current activities that offer CME/CE credit, click here.

Program Detail

Release Date: May-01-08
Credit Expiration Date: May-01-09

Faculty

Gary Richardson, MD
Henry Ford Hospital, Detroit, Michigan

David Neubauer, MD
Johns Hopkins, Baltimore, Maryland

Phyllis Zee, MD, PhD
Northwestern University, Evanston, Illinois

Credit Hours

Up to 20 AMA PRA Category 1 CreditsTM

Medium

Link - Online

Program Description

Statement of Need:

Insomnia remains inadequately identified and treated. Approximately one third of US adults report difficulty sleeping, and 10-15% have the clinical disorder of insomnia. For those patients in the primary care setting, approximately half have sleep difficulties, many undetected by health care professionals.

Activity Overview:

Postgraduate Institute for Medicine and Fortis Spectrum are launching a new CME series called TRIAD. This program is targeted toward physicians, nurse practioners and physician assistants who are committed to making practice changes in the diagnosis and management of their patients with INSOMNIA. Participants will be guided by experts through a performance improvement (PI) initiative that includes access to two webcasts (11:30AM-1:00 PM EST) and mentoring with these experts that will allow each clinician to make improvements in the care of their insomnia patients. Registration for this free program is on a first come, first served basis.

Program Developer/Facilitator

Fortis Spectrum

Target Audience

Primary care professionals.

Learning Objectives

Upon completion of this educational activity, the participant should be able to:

  1. Analyze their own knowledge gaps and other practice barriers regarding the diagnosis and treatment of patients with insomnia.
  2. Develop and implement an Action Plan designed to improve their practice in the diagnosis and treatment of patients with insomnia.
  3. Evaluate the results of their Action Plan.
  4. Assess and reflect on future opportunities for change to further improve patient care outcomes.

Disclosures

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by PIM for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Gary Richardson, MD, discloses: Consulting fees (e.g., advisory boards): Takeda Pharmaceuticals North America, Inc.; Fees for Non-CME Services Received Directly from a Commercial Interest or their Agents (e.g., speakers' bureaus): sanofi-aventis; Takeda Pharmaceuticals North America, Inc.

David Neubauer, MD, discloses: Consulting Fees (e.g., advisory boards): Neurocrine; sanofi-aventis; Takeda Pharmaceuticals North America, Inc.; Fees for Non-CME Services Received Directly from a Commercial Interest or their Agents(e.g., speakers' bureaus): sanofi-aventis; Takeda Pharmaceuticals North America, Inc.

Phyllis Zee, MD, PhD, discloses: Royalty: Lippincott and Wilkins; Consulting Fees (e.g., advisory boards): Takeda Pharmaceuticals North America, Inc.; Boehringer Ingelheim, sanofi-aventis; Jazz, GSK; Fees for Non-CME Services Received Directly from a Commercial Interest or their Agents(e.g., speakers' bureaus): Takeda Pharmaceuticals North America, Inc.; sanofi-aventis; Contracted Research: Takeda Pharmaceuticals North America, Inc.


Credit Statements

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for continuing Medical Education (ACCME) through the joint sponsorship of Postgraduate Institute for Medicine (PIM) and Fortis Spectrum. PIM is accredited by the ACCME to provide continuing medical education for physicians.

Postgraduate Institute for Medicine designates this educational activity for a maximum of 20 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

This activity is jointly sponsored by Postgraduate Institute for Medicine and Fortis Spectrum.

Commercial Support Statements

Supported by an educational grant from Takeda Pharmaceuticals North America, Inc.

Certificate Fee

$0.00

By clicking START PROGRAM I acknowledge that I have read the CME/CE information above.

Main Menu
EDITOR'S PICKS